Home Page



homePADPADD
disco4


news
companycontact linkssitemap

   h o m e  

Dialog Devices' main focus is on design, development and commercialisation of non-invasive biomedical health technology. The first application, Padd, is aimed at assessing peripheral arterial disease (PAD, reduced blood supply through legs) for preventing heart attacks and strokes.

Mission: We aspire to help meet the overwhelming demand for better healthcare through innovative optical technologies.

With the advances in opto-electronics we can now use natural light to ‘see’ below the surface of the skin non-invasively. This research has applications in all aspects of medical diagnosis and monitoring. Initially we are using this world-leading research to create products for use by healthcare workers, but in the long term we aim to introduce products for use by health-conscious consumers.
Jody Brown, Chief Executive

 

Padd in Action - video download

IET Innovation Awards - expand
Latest News

April 2008
The Department of Health awards grant to introduce Padd into primary care in the UK

March 2008
Clinical studies for post operative monitoring of peripheral interventions begin at Leeds Teaching Hospitals NHS Trust using our second product

February 2008
Aubrey Waddy and Ian Quirk join Dialog Devices to provide clinical and regulatory support

December 2007
Padd clinical studies proving PAD diagnosis published in leading journals, see
publications

May 2007
Dialog Devices Innovator of 2007 at Medilink East Midlands Healthcare Awards


October 2006
IET Innovation Awards 2006. Dialog Devices Ltd are finalists in the Start-Up category 
 

                         more news...